Kraj: Wielka Brytania
Język: angielski
Źródło: VMD (Veterinary Medicines Directorate)
Isoflurane
Piramal Healthcare UK Limited
QN01AB06
Isoflurane
Inhalation vapour, liquid
POM-V - Prescription Only Medicine – Veterinarian
Cats, Chinchilla, Dogs, Ferrets, Gerbil, Guinea Pigs, Hamsters, Horses, Mice, Ornamental Birds, Rats, Reptiles
Neurological Agent anaesthetic inhalation
Authorized
2009-08-12
Revised: August 2014 AN: 00874/2013 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Iso-Vet 1000 mg/g Inhalation Vapour, liquid (All CMS except Spain, Portugal, Sweden, Denmark, Finland & Iceland) IsoVet 1000 mg/g Inhalation Vapour, liquid (Spain & Portugal) Attane vet 1000 mg/g Inhalation Vapour, liquid (Denmark, Sweden, Finland & Iceland) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per gram: Active Substance: Isoflurane 1000 mg The veterinary medicinal product contains no excipients. 3. PHARMACEUTICAL FORM Inhalation vapour, Liquid. Clear, colourless, mobile, heavy liquid 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters, chinchillas, gerbils, guinea pigs and ferrets. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Induction and maintenance of general anaesthesia. Page 1 of 13 Revised: August 2014 AN: 00874/2013 4.3 CONTRA-INDICATIONS This product should not be used in animals with a known sensitivity to isoflurane other halogenated inhalation anesthetics or a known susceptibility to malignant hyperthermia. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The ease and rapidity of alteration of the depth of anaesthesia with Isoflurane and its low metabolism, may be considered advantageous for its use in special groups of patients such as the old or young, and those with impaired hepatic, renal or cardiac function. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Isoflurane has little or no analgesic properties. Adequate analgesia should always be given before surgery. The analgesic requirements of the patient should be considered before general anaesthesia is ended. The use of the product in patients with cardiac disease should be considered only after a risk/ benefit assessment by the veterinarian. It is important to monitor breathing and pulse for the frequency and its features. Respiratory arrest should be treated by assisted ventilation. It is important to maintain airways free and properl Przeczytaj cały dokument